shadow_tr

Breast Studies
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Development and Implementation of The Breast Cancer Collaborative Registry (BCCR)
More Information

NSABP B-51/RTOG 1304
Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
More Information

PENELOPEB
Phase III Study Evaluating Palbociclib (PD-0332991), A Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor in Patients With Hormone-Receptor-Positive, HER2-Normal Primary Breast Cancer With High Relapse Risk After Neoadjuvant Chemotherapy

NRG-BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
More Information


ECOG E2112

A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Postmenopausal Patients With Hormone Receptor-Positive Advanced Breast Cancer
More Information


 

 

1430 Tulane Ave, New Orleans, LA 70112 medsch@tulane.edu